Characteristics of the Alternative Radiopharmaceutical

  • Marc De Schrijver
Part of the Developments in Nuclear Medicine book series (DNUM, volume 16)


In order to visualise uptake of a radiopharmaceutical in a particular organ or tissue, the target organ must contain an adequate amount of tracer, and the surroundings must be as free as possible from activity. The latter can include radioactivity circulating in the blood, background activity, and adjacent activity in organs or sites unrelated to the object to be visualised.


Inflammatory Lesion Blood Clearance Data Courtesy Nuclear Medicine Centre Adjacent Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • Marc De Schrijver
    • 1
  1. 1.Radiopharmaceutical DivisionSolco Basle Ltd.BasleSwitzerland

Personalised recommendations